A study in JAMA Oncology reveals that MyProstateScore 2.0, a new urine test analyzing 18 genes, surpasses PSA in detecting significant prostate cancers and could reduce unnecessary biopsies by up to 42%.
A new urine test that measures 18 genes associated with prostate cancer provides higher accuracy for detecting clinically significant cancers than PSA and other existing biomarker tests, according to a study published on April 18 in JAMA Oncology. The urine test, MyProstateScore 2.0 (MPS2), was shown to meaningfully reduce unnecessary prostate biopsies while providing highly accurate detection of worrisome prostate cancers, the researchers concluded.
“In nearly 800 patients with an elevated PSA level, the new test was capable of ruling out the presence of clinically significant prostate cancer with remarkable accuracy. This allows patients to avoid more burdensome and invasive tests, like MRI and prostate biopsy, with great confidence that we are not missing something,” said Jeffrey Tosoian, MD, assistant professor of Urology and director of Translational Cancer Research at Vanderbilt University Medical Center, who is first author of the study.
Background on Prostate Cancer Screening
Prostate cancer is the most common cancer and the second leading cause of cancer death among men in the U.S. The PSA blood test has been widely used as the initial step in prostate cancer screening. Although PSA is elevated in the vast majority of men with prostate cancer, it is also elevated in a significant proportion of men without cancer.
As a result, the use of elevated PSA alone to prompt a prostate biopsy results in numerous unnecessary biopsies. Although generally safe, prostate biopsies are invasive, uncomfortable, and carry some risk of worrisome complications. Therefore, for patients with an elevated PSA, there is a great need for a second-line test to better identify which men truly need a biopsy and which do not.
Development of MPS2
Because some low-grade, prostate cancers do not require treatment and can be safely monitored with an approach termed active surveillance, the MPS2 test was developed to detect more specifically the higher-grade, “clinically significant” cancers in need of early detection and treatment.
To do this, the research team analyzed prostate tumors from across the U.S. to identify novel genes more often detected in the presence of significant cancers. The most informative 18 genes were combined into the MPS2 test, which was then tested in a National Cancer Institute trial of men with an elevated PSA level.
Uniquely, the authors were able to compare the novel test to other prostate cancer tests, including the original, two-gene MPS test.
Study Results and Comparison
The study involved 743 men with a median age of 62 years and a median PSA level of 5.6. While existing biomarker tests could have avoided 15% to 30% of unnecessary biopsies (i.e. biopsies that were negative or found low-grade cancers not requiring treatment), use of MPS2 would have avoided 35% to 42% of unnecessary biopsies without missing any additional diagnoses of clinically significant cancer.
The improvement was even more pronounced in men with a history of a previous negative biopsy, reducing the rate of unnecessary biopsies from 46% to 51% with use of MPS2, as compared to 9% to 21% for existing tests.
Future Research and Limitations
Multiparametric magnetic resonance imaging (mpMRI) is another second-line test that has been utilized, but while it can improve detection of clinically significant prostate cancer, interpretation of the results can be subjective and vary significantly. The authors also noted that mpMRI is not available in some community settings and is not an option for some patients. The current study was not designed to compare biomarkers to mpMRI, but the researchers are currently conducting a prospective, multicenter trial for that purpose.
In patients shown to be without clinically significant prostate cancer by the new test, the authors concluded that the “externally validated performance of MPS2 supports its effectiveness in accurately ruling out the need for mpMRI and biopsy altogether.” They noted a limitation of the study was that only 13% of participants were African American. Because prostate cancer is more prevalent among African American men, the research team is currently pursuing further analyses in more racially diverse populations.
For more on this research, see New Urine-Based Test Detects High-Grade Prostate Cancer.
Reference: “Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer” by Jeffrey J. Tosoian, Yuping Zhang, Lanbo Xiao, Cassie Xie, Nathan L. Samora, Yashar S. Niknafs, Zoey Chopra, Javed Siddiqui, Heng Zheng, Grace Herron, Neil Vaishampayan, Hunter S. Robinson, Kumaran Arivoli, Bruce J. Trock, Ashley E. Ross, Todd M. Morgan, Ganesh S. Palapattu, Simpa S. Salami, Lakshmi P. Kunju, Scott A. Tomlins, Lori J. Sokoll, Daniel W. Chan, Sudhir Srivastava, Ziding Feng, Martin G. Sanda, Yingye Zheng, John T. Wei, Arul M. Chinnaiyan, EDRN-PCA3 Study Group, Ian M. Thompson, Mohamed Bidair, Adam Kibel, Daniel W. Lin, Yair Lotan, Alan Partin, Samir Taneja, David H. Howard, Meredith M. Regan, Jack Groskopf, Jonathan Chipman, Dattatraya H. Patil, Douglas S. Scherr, Jacob Kagan, Jing Fan, Aron Y. Joon, Leonidas E. Bantis and Mark A. Rubin, 18 April 2024, JAMA Oncology.
DOI: 10.1001/jamaoncol.2024.0455
Tosoian is co-first author with Yuping Zhang, PhD, and Lanbo Xiao, PhD, professors at the University of Michigan, where Tosoian and Arul Chinnaiyan, MD, PhD, initiated the study. Chinnaiyan and John T. Wei, MD, are the study’s senior authors. Other Vanderbilt researchers who contributed to the study are Nathan Samora, MD, and Hunter Robinson, MD.
The study received funding support from the Prostate Cancer Foundation Young Investigator Award (Tosoian), Michigan-Vanderbilt EDRN Biomarker Characterization Center (U2C CA271854), and the EDRN DMCC (U24 CA086368).
News
This modified stainless steel could kill bacteria without antibiotics or chemicals
An electrochemical process developed at Georgia Tech could offer new protection against bacterial infections without contributing to growing antibiotic resistance. The approach capitalizes on the natural antibacterial properties of copper and creates incredibly small [...]
Mask Myth Busted? New Research Reveals That Wearing Face Masks Did Not Reduce Risk of COVID Infection
A new study indicates that face masks did not significantly lower Covid-19 infection risk after the initial Omicron wave, highlighting the need for adaptable strategies and further research as risk factors evolve. New findings [...]
Unlocking Cancer’s Code: Johns Hopkins Researchers Reveal How Cells Go Rogue
Scientists at Johns Hopkins Medicine have mapped a molecular pathway in human breast and lung cells that could lead to excessive genome duplication, a hallmark of cancer cells. The findings, recently published in the journal Science, reveal [...]
Scientists Uncover Unexpected Hidden Dangers of a Common Antibiotic
In emergency rooms and intensive care units nationwide, healthcare professionals must quickly decide on antibiotics for patients suspected of having severe infections. A recent study from the University of Michigan indicates that these rapid decisions could [...]
New research to make digital transactions quantum safe and 20 times faster
A team of experts, including Monash University researchers, has developed a new technique to implement quantum-safe digital signatures twenty times faster, resulting in speedier and safer online transactions than ever before. The research, published recently [...]
Scientists use generative AI to answer complex questions in physics
When water freezes, it transitions from a liquid phase to a solid phase, resulting in a drastic change in properties like density and volume. Phase transitions in water are so common most of us [...]
An easy pill to swallow—new 3D printing research paves way for personalized medication
A new technique for 3D printing medication has enabled the printing of multiple drugs in a single tablet, paving the way for personalized pills that can deliver timed doses. Researchers from the University of [...]
Revolutionary “Quartet Nanocage” Vaccine Effective Against Coronaviruses That Haven’t Even Emerged Yet
Researchers have created a new vaccine technology that, in tests with mice, has demonstrated protection against a wide variety of coronaviruses, including those that could cause future disease outbreaks—even those not yet identified. This [...]
Researchers Warn: AI Systems Have Already Learned How To Deceive Humans
Numerous artificial intelligence (AI) systems, even those designed to be helpful and truthful, have already learned how to deceive humans. In a review article recently published in the journal Patterns, researchers highlight the dangers of [...]
MIT’s New MRI Technique Reveals Hidden Light Deep in the Brain
A novel MRI technique developed at MIT allows for detailed imaging of bioluminescence deep within the brain, offering new insights into how brain cells develop and communicate with each other. Scientists often label cells with proteins [...]
Revolutionary mRNA Cancer Vaccine Shows Immense Promise in First-Ever Human Clinical Trial
In a first-ever human clinical trial of four adult patients, an mRNA cancer vaccine created at the University of Florida rapidly reprogrammed the immune system to target glioblastoma, the deadliest and most aggressive form of brain [...]
Human brain map contains never-before-seen details of structure
A cubic millimeter of brain tissue may not sound like much. But considering that tiny square contains 57,000 cells, 230 millimeters of blood vessels, and 150 million synapses, all amounting to 1,400 terabytes of [...]
AI Ethics Surpass Human Judgment in New Moral Turing Test
AI’s ability to address moral questions is improving, which prompts further considerations for the future. A recent study revealed that when individuals are given two solutions to a moral dilemma, the majority tend to [...]
AstraZeneca removes its Covid vaccine worldwide after rare side effect
AstraZeneca withdraws COVID-19 vaccine: The pharmaceutical giant AstraZeneca's COVID-19 vaccine is being withdrawn worldwide after the company acknowledged for the first time in court documents that it can cause a rare and dangerous side [...]
AI Transforms Drug Discovery With Faster, Safer Cancer Treatments
The new platform helped UC San Diego scientists synthesize 32 potential multi-target cancer drugs. Scientists at UC San Diego have developed a machine learning algorithm to simulate the time-consuming chemistry involved in the earliest phases of [...]
Nanotech opens door to future of insulin medication
An international team, led by researchers from Australia, have developed a system using nanotechnology that could allow people with diabetes to take oral insulin in the future. The researchers say the new insulin could [...]